Open Orphan, the Dublin-listed pharmaceutical services company run by Cathal Friel, has announced that its hVIVO subsidiary has signed a £5 million contract with a European biotechnology company.
Under the terms of the contract, the European biotech company will test its intravenous antiviral candidate using the Hvivo human challenge study model for respiratory syncytial virus , an illness which affects the respiratory tract of children and at-risk adults. In severe cases it can...
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Former chief justice Clarke defends legal work for retired judges | Business PostFormer chief justice Clarke defends legal work for retired judges, sanzscript reports.
ادامه مطلب »
Making It Work: How a business was born in the aftermath of a tragedy | Business PostA sudden family bereavement ended up being the catalyst for Gillian Rijke to found her own home accessories business Lily Pad
ادامه مطلب »